Cargando…
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis
Several biologic therapies have been developed to treat moderate-to-severe psoriasis, with patients exhibiting different clinical benefits, possibly due to the heterogeneity of pathogenic processes underlying their conditions. Ustekinumab targets the IL-12/IL-23-p40 subunit and inhibits type-1 and t...
Autores principales: | Morelli, Martina, Galluzzo, Marco, Scarponi, Claudia, Madonna, Stefania, Scaglione, Giovanni Luca, Girolomoni, Giampiero, Talamonti, Marina, Bianchi, Luca, Albanesi, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695538/ https://www.ncbi.nlm.nih.gov/pubmed/36423071 http://dx.doi.org/10.3390/vaccines10111977 |
Ejemplares similares
-
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019) -
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis
por: Morelli, Martina, et al.
Publicado: (2018) -
Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development
por: Fania, Luca, et al.
Publicado: (2019) -
PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis
por: Mercurio, Laura, et al.
Publicado: (2021) -
HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis
por: Wiśniewski, Andrzej, et al.
Publicado: (2018)